These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10270308)

  • 1. Pharmacy newsletters: time for a new approach.
    Mitchell JF
    Hosp Formul; 1985 Mar; 20(3):360, 363-5. PubMed ID: 10270308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a P & T committee newsletter on anti-infective prescribing habits.
    Lyon RA; Norvell MJ
    Hosp Formul; 1985 Jun; 20(6):742-4. PubMed ID: 10271477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugman--a computerized supplement to a hospital's drug information newsletter.
    Mok MP; Castile JA; Kowaloff HB; Janousek JR
    Am J Hosp Pharm; 1985 Jul; 42(7):1565-7. PubMed ID: 4025355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptance of a pharmacy-based, physician-edited hospital pharmacy and therapeutics committee newsletter.
    Ritchie DJ; Manchester RF; Rich MW; Rockwell MM; Stein PM
    Ann Pharmacother; 1992; 26(7-8):886-9. PubMed ID: 1504393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty years' experience with drug information centers.
    Amerson AB; Wallingford DM
    Am J Hosp Pharm; 1983 Jul; 40(7):1172-8. PubMed ID: 6881155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic approach to writing P&T drug reports.
    Longe RL
    Hosp Formul; 1978 Feb; 13(2):128-9. PubMed ID: 10306341
    [No Abstract]   [Full Text] [Related]  

  • 8. [Future drug committees--institutions for cooperation and information].
    Odeberg H; Lenhoff K
    Lakartidningen; 1989 Jan; 86(1-2):34. PubMed ID: 2911227
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy newsletters--the journalistic approach.
    Almquist AF; Wolfgang AP; Perri M
    Hosp Pharm; 1988 Nov; 23(11):974-5. PubMed ID: 10290756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug committees, choice of drugs and drug information].
    Lundh B
    Lakartidningen; 1988 Nov; 85(44):3641-3. PubMed ID: 3199994
    [No Abstract]   [Full Text] [Related]  

  • 12. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use review using the "target drug" method.
    Puckett F; Baars R; Seay K
    Hosp Formul; 1987 May; 22(5):489-91. PubMed ID: 10281733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of drug reports for the P&T Committee.
    Longe RL; Cross GW; Riley MW
    Hosp Formul; 1978 Mar; 13(3):228-9. PubMed ID: 10306915
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
    Segal R; Pathak DS
    Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.